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Abstract 
Human cytomegalovirus (HCMV) is exquisitely adapted to the human host, and much research has 
focused on its evolution over long timescales spanning millennia. Here, we review recent data exploring 
the evolution of the virus on much shorter timescales, on the order of days or months. We describe the 
intrahost genetic diversity of the virus isolated from humans, and how this diversity contributes to HCMV 
spatiotemporal evolution. We propose mechanisms to explain the high levels of intrahost diversity and 
discuss how this new information may shed light on HCMV infection and pathogenesis.  
Introduction 
Collectively, the cytomegaloviruses are ancient viruses that appear to infect the majority of vertebrates, 
but each particular cytomegalovirus infects a single host species with little evidence that the viruses jump 
between hosts. These traits have contributed to cytomegaloviruses adapting over long time scales (e.g. 
millennia) to the particular ecological niches in which they occupy. In particular, human cytomegalovirus is 
a β-herpesvirus that produces lifelong infections in most humans. In most individuals, HCMV infections 
result in a mild febrile illness, but can lead to severe symptoms in the immune-compromised or neonates. 
Nearly all HCMV infections result in widespread dissemination throughout the body, with diverse cell 
types such as epithelial, endothelial, fibroblast, and smooth muscle cells supporting productive viral 
infection. Further, the virus induces a myriad of immunomodulatory pathways to subvert the host innate 
and adaptive response [1]. Many excellent studies and reviews (for example, see [2] or [3]) have focused 
on the long term evolution of the virus and have highlighted the molecular characteristics that have 
helped create a highly successful pathogen. However, work mostly from the past decade has shown that 
the virus evolves on much shorter timescales, on the order of days or months, and within individual 
infected hosts. The purpose of this review is to discuss recent findings illustrating the complexity of short-
term HCMV evolution and how it may relate to clinical manifestations of infection.  
Diversity of Human Cytomegalovirus in Human Hosts 
Work published more than 30 years ago based on restriction length polymorphisms (RFLP) has shown 
that HCMV exhibits unexpected levels of genetic diversity between individuals (i.e., interhost variability) 
[4]. These results were later confirmed with targeted re-sequencing of genetic loci, primarily focusing on 
glycoproteins such as gB, gN and g0, as well as whole genome data from both low passage isolates and 
clinical samples [5,6]. However, work reported more recently has shown that HCMV also exhibits 
significant levels of genetic diversity within a single individual (i.e., intrahost diversity). Similar to interhost 
variability, most intrahost diversity data has focused on the HCMV glycoproteins. Various assays, such as 
PCR-RFLP [7], DNA sequencing [8], single strand conformation polymorphism [9] and heteroduplex 
mobility analysis [9], show that these regions can be variable within individuals. However, these studies 
were limited by the technologies available, and suffered from issues associated with low sampling depth 
and narrow breadth of the HCMV genome. Nevertheless, they regularly showed that mixed infections 
accounted for roughly one quarter to one half of HCMV infections over a wide range of human 
populations, including infants with congenital infection [10], people with HIV/AIDS [11,12], transplant 
recipients, and immunocompetent children [13] and adults [14]. An important paper from 2011 began to 
show the full extent of HCMV intrahost diversity by using ultra-deep pyrosequencing to study the gO, gN 
and gH loci from HCMV-infected transplant recipients [15]. They found that all patients studied had mixed 
infections, with as many as 6 genotypes observed in a single patient. Similarly, deep sequencing of 
81,224 base pairs of the HCMV genome directly from a glioblastoma multiforme (GBM) tumor revealed 
high genetic diversity of the virus including an overabundance of hypervariable loci, in which all four 
nucleotides were observed at a single position in the viral genome. Work that combined genomics with 
high throughput sequencing showed that HCMV diversity was not limited to a subset of loci, but rather 
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spanned the entire genome [16]. In fact, nearly every open reading frame (ORF) of the HCMV genome 
exhibited a measurable level of intrahost genetic diversity. Importantly, HCMV diversity was described 
quantitatively using various metrics and shown to rival that of some RNA viruses, the benchmark of highly 
diverse viral populations (Figure 1). From these studies, it has been become clear that HCMV is highly 
diverse within humans. 
Mechanisms of HCMV Diversity 
Given the high levels of HCMV intrahost diversity, examination of its source is warranted. Currently, there 
is no clear mechanism to explain the observed diversity, though the literature does offer several non-
mutually exclusive mechanisms that could be playing a role. High levels of replication during primary 
infection could contribute to the generation of de novo mutations in each host, though the total number of 
mutations generated may be limited by the proofreading activity of the viral DNA polymerase [17]. The 
excess of low frequency mutations in HCMV intrahost populations [15] as well as the star phylogeny of 
clones sampled from the populations [16] are consistent with this pattern (Figure 2A). However, clones 
from HCMV clinical samples also reveal that some members of the population are highly divergent from 
the most common sequence, a result consistent with reinfection (Figure 2B). HCMV reinfections appear to 
be common in both immunocompromised and healthy individuals [4,18-20]. Indeed, reinfections in some 
populations may occur at an annualized rate of 10%, comparable to the annualized rate of new infections 
[21]. Thus, reinfections offer a route for repeatedly introducing diversity into HCMV intrahost populations. 
However, this mechanism does not immediately appear to address the diversity observed in very young 
patients, specifically congenitally infected neonates. Here, the explanation may lie in the transplacental 
route of transmission associated with congenital infection. One recent study showed that maternal-to-fetal 
transmission may represent 10s to 100s of unique HCMV virions [22]. In contrast, transmission 
associated with RNA viruses is associated with a much lower number of virions, with bottlenecks so 
restrictive that only a single sequence transmits as in the case of HIV [23,24]. In this extreme case of a 
single virion transmission, all pre-existing viral population diversity is lost and must be generated de novo 
during replication in the newly infected host. More relaxed bottlenecks would result in 100s of HCMV 
virions being transmitted during congenital infections. In this circumstance, a portion of the pre-existing 
diversity present in the mother may be transmitted to the fetus. Whether this mechanism contributes to 
HCMV diversity in other transmission contexts, such as in healthy children or adults, is unknown.  
The two mechanisms of recombination and natural selection may also alter HCMV intrahost diversity. For 
other organisms, a positive correlation has been shown between recombination rate and diversity [25]. 
Both positive selection of beneficial alleles and negative selection against deleterious alleles will reduce 
diversity at a locus due to the fixation or clearance of mutations, respectively [26,27]. By uncoupling 
neutral variation from the beneficial or deleterious alleles, recombination can allow for higher levels of 
neutral variation to remain in the population. There is ample evidence of recombination in the HCMV 
genome [28-31], so this mechanism may play a role in shaping HCMV diversity. However, to date the 
recombination rate has not been quantified across the HCMV genome, while only a limited number of 
studies have analyzed the strength or frequency of selection targeting HCMV intrahost populations.  
Change of Populations in Human Hosts 
With such high levels of intrahost diversity, researchers began to ask whether this leads to highly dynamic 
viral populations. For example, do the frequencies of specific mutations or genotypes change over time, 
and if so, how rapidly? Much research suggests that HCMV populations are generally stable over time. 
Longitudinal evolution studies of HCMV have predominantly focused on solid organ transplant recipients. 
In this patient population, genotyping via qPCR and sequencing of HCMV loci have shown mixed viral 
populations, but the composition of the mixed populations remains nearly constant in most patients over 
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time [32-35]. A longitudinal study of congenitally infected infants showed similarly stable populations [22]. 
The predominant pattern from this work shows that HCMV populations contain a dominant sequence 
(which may represent > 90% of the total viral population) while the remaining population is occupied by a 
diverse array of largely stable sequences (i.e. minor variants) [15,16].  
However, some caveats should be considered with this statement of longitudinal genetic stability. First, 
there may exist many thousands of stable mutations in an HCMV population [15,16,22,36] that do not rise 
in frequency over time, but importantly, are also not cleared from the population. These stable mutations 
(i.e., standing variation) provide a mechanism by which the virus could rapidly adapt to changing 
environments, such as new host compartments, immune pressure or antiviral drugs. Second, even if most 
mutations are stable, the change of only a few can dramatically alter viral fitness or pathogenesis. The 
increase in frequency of antiviral drug resistance mutations [37-39] clearly illustrates this point. 
Interestingly, antiviral treatment has also been shown to cause changes in non-drug resistance 
associated loci, such as gB, presumably due to linkage with a drug resistance mutation [33]. Lastly, 
HCMV populations that undergo spatial compartmentalization, as discussed in the next section, appear to 
undergo rapid evolution. 
Tissue compartmentalization of HCMV in Human Hosts 
A hallmark of HCMV infections is dissemination to a wide range of host tissue compartments and cell 
types [40]. Due to the high levels of diversity associated with HCMV infections, researchers have begun 
to study whether viral diversity sampled from compartments differ, both in total level of variation and in 
specific genetic or genomic sequences observed. Indeed, early reports of diverse HCMV infections also 
demonstrated that HCMV sampled from different organs of healthy individuals could differ in gB genotype 
composition [14,41]. This finding has been supported in subsequent work studying other genomic loci 
[10,33,42]. Quantitative descriptions of the diversity have demonstrated significant differences in the level 
of diversity between compartments, with blood populations appearing more diverse than urine or 
intraocular populations [7,22]. However, the most striking example of compartmentalization may be 
differences in drug resistance genotypes observed in some patients. Several studies have shown that 
ganciclovir (GCV) resistance genotypes are not evenly distributed in patient compartments during 
treatment [43-46], with, for example, drug sensitive strains present in the cerebrospinal fluid and drug 
resistant strains in the blood [46].  
Although the mechanism(s) explaining compartmentalization are not clear, there are at least two 
hypotheses that can be proposed. First, compartmentalization could result from the stochasticity of 
dissemination. Bottlenecking of the viral populations during dissemination will increase the proportion of 
mutations in the population that are governed by stochastic fluctuations in frequency (i.e., genetic drift) 
[47]. These stochastic changes can drastically skew the composition of populations in the distal relative to 
the original compartment [48]. Second, compartmentalization could result from natural selection during 
dissemination. Selection for mutants more fit in a compartment, for example due to cellular tropism, could 
lead to distinct populations in that tissue. Few studies have tested between these two models. There is 
evidence that selection [49] or both bottlenecks and selection can explain the observed 
compartmentalization [22] but the phenomenon needs to be studied in a wider range of patient 
populations to distinguish between these possibilities.  
HCMV Diversity, Evolution and Clinical Disease: Is there a connection? 
We are now developing a clearer understanding of HCMV intrahost genetic diversity and evolution, but 
there is still the looming question of how these observations inform our understanding of HCMV disease. 
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While this question is clinically relevant, work connecting diversity and pathogenesis is not fully 
developed, so discussion of its implications remains more speculative than others.  
Many conflicting reports have examined the correlation between variation of HCMV genotype sequences 
and risk of transmission or disease progression and severity [41,50-54]. From this work, no clear 
conclusion can be reached about a possible effect of any single genotype on disease. However, 
subsequent research has shown that mixed genotype infections do correlate with increased viral load, 
HCMV disease severity, and even progression to AIDS in people with HIV infection [7,8,55,56]. Further, 
studies of intrauterine transmission of mothers with preconceptional immunity showed a higher rate of 
transmission and symptomatic congenital infections in mothers who were reinfected during pregnancy as 
compared to those who were not reinfected [18,19]. From these data, it is not clear if reinfection per se or 
merely the presence of multiple strains lead to the clinical outcomes. It has been demonstrated in a 
mouse model of cytomegalovirus infection that in vivo complementation occurs due to co-infection, 
allowing for the replication and dissemination of an attenuated strain due to transcomplementation from a 
wild type strain [57]. Thus, it is possible that multiple strain infections alter HCMV fitness by allowing a 
largely haploid virus to act as a polyploid.  
Two specific areas where HCMV intrahost diversity may alter pathogenesis are dissemination and 
immune evasion. The possible role in dissemination is based on studies of the viral glycoproteins, 
proteins important in cell-to-cell spread and tissue tropism. In one report, many gB sequences were 
isolated from urine samples, but only a subtype of sequences were associated with plasma, suggesting 
that genetic diversity influences tissue tropism of the virus [41]. Similarly, variation in the gO protein alters 
the ratio of the endothelial-tropic gH/gL/UL128-131 complex to the fibroblast-tropic gH/gL/gO complex 
and thus was proposed to alter tropism and viral dissemination. From these data, it is possible to 
speculate that a diverse population of HCMV may harbor a subset of mutants that better replicate in 
distinct host compartments, and that viral diversity therefore enhances viral dissemination. In addition to 
dissemination, the possible effect of immune evasion on the relationship between viral intrahost diversity 
and pathogenesis has been suggested but not clearly proven. HCMV infections are regulated by both 
innate and adaptive immune responses. Variation in the UL40 gene product modulates NK-cell mediated 
immunosurveillance by altering interaction of HLA-E with the CD94-NKG2A inhibitory receptor [58]. In 
studies of congenital infections, the intrahost diversity of UL40, particularly in the HLA-E binding domain, 
is significantly higher than the genome wide average [16]. Thus, mutants in the population likely display 
varied phenotypes in terms of NK-cell evasion, which may have profound effects on viral pathogenesis 
and the balance between productive and latent infections. Similar to NK cell evasion, variation in CD8
+ 
T 
cell epitopes can alter the host adaptive immune response. Primary infection with mixed strains leads to 
the production of cross-reactive T cells, though exposure to some viral variants may limit the range of 
epitopes and viruses recognized by the T cell population [59]. Further, epitope recognition of the host T 
cell response has been shown to broaden over time in congenital infections [60], and thus may select 
against a wide range of viral mutations. Whether viral diversity is altered by and/or drives the adaptive 
immune response is unclear. Future work is needed to elucidate the directionality of this dynamic 
relationship between HCMV and its human host and the contribution of pre-existing and de novo viral 
mutants in the process.  
Conclusions and Future Directions 
Here we highlight a few areas in which additional study could provide valuable information for ongoing 
and future efforts to lessen the burden of HCMV disease. An increasing body of evidence has 
demonstrated that HCMV is genetically diverse in human hosts, and there is tantalizing evidence that this 
diversity may contribute to pathogenesis. As such, HCMV intrahost diversity will remain as an important 
avenue to explore when developing novel antivirals and effective vaccines against this virus, as well as in 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/009571doi: bioRxiv preprint first posted online Sep. 25, 2014; 
designing treatment regimens - with previous results in other viruses suggesting that reduced diversity 
may indeed be associated with decreased pathogenesis [61,62]. Yet, in order for HCMV diversity to 
become a therapeutic target, it is necessary to better characterize the evolutionary processes responsible 
for this diversity. Relatedly, the need remains to better explore the observed correlative relationship 
between HCMV diversity and disease in order to disentangle cause from effect, and in so doing 
characterize the number of mutations important for the ultimate disease phenotype. Finally, relatively little 
attention has been given thus far to virus-host interactions, and further illuminating the role of variable 
host genetics as well as the co-evolutionary relationship between these organisms will likely become 
fruitful as sequencing costs continue to fall, thus enabling large scale paired human-HCMV sequencing 
duos. Encouraging, with these continued advances on the intersection of virology and population 
genetics, there is every reason to be optimistic that these aims will result in new tools to aid in our 
ongoing struggle with HCMV.  
Acknowledgments 
We wish to thank our many colleagues who provided specimens from HCMV-infected patients that 
contributed to our understanding of intrahost evolution. This publication was supported by a grant from 
the National Institutes of Health (R01HD061959). The contents of this publication are solely the 
responsibility of the authors and do not necessarily represent the official views of the NIH. 
 
  
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/009571doi: bioRxiv preprint first posted online Sep. 25, 2014; 
References 
1. Mocarski ES (2002) Immunomodulation by cytomegaloviruses: manipulative strategies beyond 
evasion. Trends in Microbiology 10: 332-339. 
2. McGeoch DJ, Rixon FJ, Davison AJ (2006) Topics in herpesvirus genomics and evolution. Virus Res 117: 
90-104. 
3. Davison AJ (2011) Evolution of sexually transmitted and sexually transmissible human herpesviruses. 
Annals of the New York Academy of Sciences 1230: E37-E49. 
4. Huang ES, Huong SM, Tegtmeier GE, Alford C (1980) Cytomegalovirus: genetic variation of viral 
genomes. Ann N Y Acad Sci 354: 332-346. 
5. Bradley AJ, Lurain NS, Ghazal P, Trivedi U, Cunningham C, et al. (2009) High-throughput sequence 
analysis of variants of human cytomegalovirus strains Towne and AD169. J Gen Virol 90: 2375-
2380. 
6. Cunningham C, Gatherer D, Hilfrich B, Baluchova K, Dargan DJ, et al. (2009) Sequences of complete 
human cytomegalovirus genomes from infected cell cultures and clinical specimens. J Gen Virol 
91: 605-615. 
7. Sowmya P, Madhavan HN (2009) Analysis of mixed infections by multiple genotypes of human 
cytomegalovirus in immunocompromised patients. J Med Virol 81: 861-869. 
8. Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, et al. (2004) Mixed Cytomegalovirus 
Glycoprotein B Genotypes in Immunocompromised Patients. Clin Infect Dis 39: 155-161. 
9. Trincado DE, Scott GM, White PA, Hunt C, Rasmussen L, et al. (2000) Human cytomegalovirus strains 
associated with congenital and perinatal infections. J Med Virol 61: 481-487. 
10. Ross SA, Novak Z, Pati S, Patro RK, Blumenthal J, et al. (2011) Mixed infection and strain diversity in 
congenital cytomegalovirus infection. J Infect Dis 204: 1003-1007. 
11. Spector SA, Hirata KK, Neuman TR (1984) Identification of Multiple Cytomegalovirus Strains in 
Homosexual Men with Acquired Immunodeficiency Syndrome. Journal of Infectious Diseases 
150: 953-956. 
12. Drew WL, Sweet ES, Miner RC, Mocarski ES (1984) Multiple infections by cytomegalovirus in patients 
with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J 
Infect Dis 150: 952-953. 
13. Numazaki K, Ikehata M, Asanuma H, Chiba S (1998) Simultaneous infection of immunocompetent 
individuals with multiple cytomegalovirus strains. The Lancet 352: 1710. 
14. Meyer-König U, Ebert K, Schrage B, Pollak S, Hufert FT (1998) Simultaneous infection of healthy 
people with multiple human cytomegalovirus strains. The Lancet 352: 1280-1281. 
15. Görzer I, Guelly C, Trajanoski S, Puchhammer-Stockl E (2010) Deep sequencing reveals highly 
complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J Virol: 
JVI.00475-00410. 
16. Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF (2011) Extensive Genome-Wide 
Variability of Human Cytomegalovirus in Congenitally Infected Infants. PLoS Pathog 7: e1001344. 
17. Chou S, Marousek GI (2008) Accelerated evolution of maribavir resistance in a cytomegalovirus 
exonuclease domain II mutant. J Virol 82: 246-253. 
18. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ (2001) Intrauterine Transmission of 
Cytomegalovirus to Infants of Women with Preconceptional Immunity. New England Journal of 
Medicine 344: 1366-1371. 
19. Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VM, et al. (2010) Human 
cytomegalovirus reinfection is associated with intrauterine transmission in a highly 
cytomegalovirus-immune maternal population. American Journal of Obstetrics and Gynecology 
202: 297.e291-297.e298. 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/009571doi: bioRxiv preprint first posted online Sep. 25, 2014; 
20. Bale Jr JF, Petheram SJ, Souza IE, Murph JR (1996) Cytomegalovirus reinfection in young children. 
The Journal of Pediatrics 128: 347-352. 
21. Ross SA, Arora N, Novak Z, Fowler KB, Britt WJ, et al. (2010) Cytomegalovirus Reinfections in Healthy 
Seroimmune Women. Journal of Infectious Diseases 201: 386-389. 
22. Renzette N, Gibson L, Bhattacharjee B, Fisher D, Schleiss MR, et al. (2013) Rapid Intrahost Evolution 
of Human Cytomegalovirus Is Shaped by Demography and Positive Selection. PLoS Genet 9: 
e1003735. 
23. Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, et al. (2010) Transmission of single HIV-1 
genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 5: 
e12303. 
24. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008) Identification and 
characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. 
Proceedings of the National Academy of Sciences 105: 7552-7557. 
25. Begun DJ, Aquadro CF (1992) Levels of naturally occurring DNA polymorphism correlate with 
recombination rates in D. melanogaster. Nature 356: 519-520. 
26. Maynard-Smith J, Haigh J (1974) The hitch-hiking effect of a favourable gene. Genet Res 23: 23-35. 
27. Charlesworth B, Morgan MT, Charlesworth D (1993) The effect of deleterious mutations on neutral 
molecular variation. Genetics 134: 1289-1303. 
28. Yan H, Koyano S, Inami Y, Yamamoto Y, Suzutani T, et al. (2008) Genetic linkage among human 
cytomegalovirus glycoprotein N (gN) and gO genes, with evidence for recombination from 
congenitally and post-natally infected Japanese infants. J Gen Virol 89: 2275-2279. 
29. Meyer-König U, Haberland M, von Laer D, Haller O, Hufert FT (1998) Intragenic variability of human 
cytomegalovirus glycoprotein B in clinical strains. J Infect Dis 177: 1162-1169. 
30. Haberland M, Meyer-König U, Hufert FT (1999) Variation within the glycoprotein B gene of human 
cytomegalovirus is due to homologous recombination. Journal of General Virology 80: 1495-
1500. 
31. Steininger C, Schmied B, Sarcletti M, Geit M, Puchhammer-Stockl E (2005) Cytomegalovirus 
genotypes present in cerebrospinal fluid of HIV-infected patients. AIDS 19: 273-278. 
32. Garrigue I, Corte MF-D, Magnin N, Recordon-Pinson P, Couzi L, et al. (2008) UL40 Human 
Cytomegalovirus Variability Evolution Patterns Over Time in Renal Transplant Recipients. 
Transplantation 86: 826-835 810.1097/TP.1090b1013e3181859edd. 
33. Görzer I, Kerschner H, Jaksch P, Bauer C, Seebacher G, et al. (2008) Virus load dynamics of individual 
CMV-genotypes in lung transplant recipients with mixed-genotype infections. J Med Virol 80: 
1405-1414. 
34. Puchhammer-Stockl E, Gorzer I, Zoufaly A, Jaksch P, Bauer CC, et al. (2006) Emergence of multiple 
cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 81: 187-
194. 
35. Stanton R, Westmoreland D, Fox JD, Davison AJ, Wilkinson GW (2005) Stability of human 
cytomegalovirus genotypes in persistently infected renal transplant recipients. J Med Virol 75: 
42-46. 
36. Bhattacharjee B, Renzette N, Kowalik TF (2012) Genetic Analysis of Cytomegalovirus in Malignant 
Gliomas. Journal of Virology 86: 6815-6824. 
37. Springer KL, Chou S, Li S, Giller RH, Quinones R, et al. (2005) How Evolution of Mutations Conferring 
Drug Resistance Affects Viral Dynamics and Clinical Outcomes of Cytomegalovirus-Infected 
Hematopoietic Cell Transplant Recipients. Journal of Clinical Microbiology 43: 208-213. 
38. Chou S, Marousek G, Guentzel S, Follansbee SE, Poscher ME, et al. (1997) Evolution of Mutations 
Conferring Multidrug Resistance during Prophylaxis and Therapy for Cytomegalovirus Disease. 
Journal of Infectious Diseases 176: 786-789. 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/009571doi: bioRxiv preprint first posted online Sep. 25, 2014; 
39. Eckle T, Lang P, Prix L, Jahn G, Klingebiel T, et al. (2002) Rapid development of ganciclovir-resistant 
cytomegalovirus infection in children after allogeneic stem cell transplantation in the early 
phase of immune cell recovery. Bone Marrow Transplant 30: 433-439. 
40. Sinzger C, Grefte A, Plachter B, Gouw ASH, The TH, et al. (1995) Fibroblasts, epithelial cells, 
endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection 
in lung and gastrointestinal tissues. Journal of General Virology 76: 741-750. 
41. Meyer-König U, Vogelberg C, Bongarts A, Kampa D, Delbrück R, et al. (1998) Glycoprotein B genotype 
correlates with cell tropism in vivo of human cytomegalovirus infection. Journal of Medical 
Virology 55: 75-81. 
42. Beyari MM, Hodgson TA, Kondowe W, Molyneux EM, Scully C, et al. (2005) Inter- and intra-person 
cytomegalovirus infection in Malawian families. J Med Virol 75: 575-582. 
43. Hamprecht K, Eckle T, Prix L, Faul C, Einsele H, et al. (2003) Ganciclovir-Resistant Cytomegalovirus 
Disease after Allogeneic Stem Cell Transplantation: Pitfalls of Phenotypic Diagnosis by In Vitro 
Selection of an UL97 Mutant Strain. Journal of Infectious Diseases 187: 139-143. 
44. Prix L, Hamprecht K, Holzhüter B, Handgretinger R, Klingebiel T, et al. (1999) Comprehensive 
Restriction Analysis of the UL97 Region Allows Early Detection of Ganciclovir-Resistant Human 
Cytomegalovirus in an Immunocompromised Child. Journal of Infectious Diseases 180: 491-495. 
45. Eckle T, Prix L, Jahn G, Klingebiel T, Handgretinger R, et al. (2000) Drug-resistant human 
cytomegalovirus infection in children after allogeneic stem cell transplantation may have 
different clinical outcomes. Blood 96: 3286-3289. 
46. Frange P, Boutolleau D, Leruez-Ville M, Touzot F, Cros G, et al. (2013) Temporal and Spatial 
Compartmentalization of Drug-Resistant Cytomegalovirus (CMV) in a Child with CMV 
Meningoencephalitis: Implications for Sampling in Molecular Diagnosis. Journal of Clinical 
Microbiology 51: 4266-4269. 
47. Monsion B, Froissart R, Michalakis Y, Blanc S (2008) Large bottleneck size in Cauliflower Mosaic Virus 
populations during host plant colonization. PLoS Pathog 4: e1000174. 
48. Nei M, Maruyama T, Chakraborty R (1975) Bottleneck Effect and Genetic Variability in Populations. 
Evolution 29: 1-10. 
49. McWhorter AR, Smith LM, Masters LL, Chan B, Shellam GR, et al. (2013) Natural Killer Cell 
Dependent Within-Host Competition Arises during Multiple MCMV Infection: Consequences for 
Viral Transmission and Evolution. PLoS Pathog 9: e1003111. 
50. Humar A, Kumar D, Gilbert C, Boivin G (2003) Cytomegalovirus (CMV) Glycoprotein B Genotypes and 
Response to Antiviral Therapy, in Solid-Organ-Transplant Recipients with CMV Disease. J Infect 
Dis 188: 581-584. 
51. Tanaka K, Numazaki K, Tsutsumi H (2005) Human cytomegalovirus genetic variability in strains 
isolated from Japanese children during 1983-2003. J Med Virol 76: 356-360. 
52. Revello MG, Campanini G, Piralla A, Furione M, Percivalle E, et al. (2008) Molecular epidemiology of 
primary human cytomegalovirus infection in pregnant women and their families. J Med Virol 80: 
1415-1425. 
53. Mao ZQ, He R, Sun M, Qi Y, Huang YJ, et al. (2007) The relationship between polymorphisms of 
HCMV UL144 ORF and clinical manifestations in 73 strains with congenital and/or perinatal 
HCMV infection. Arch Virol 152: 115-124. 
54. Gilbert C, Handfield J, Toma E, Lalonde R, Bergeron MG, et al. (1999) Human cytomegalovirus 
glycoprotein B genotypes in blood of AIDS patients: lack of association with either the viral DNA 
load in leukocytes or presence of retinitis. J Med Virol 59: 98-103. 
55. Leach CT, Detels R, Hennessey K, Liu Z, isscher BR, et al. (1994) A Longitudinal Study of 
Cytomegalovirus Infection in Human Immunodeficiency Virus Type I-Seropositive Homosexual 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/009571doi: bioRxiv preprint first posted online Sep. 25, 2014; 
Men: Molecular Epidemiology and Association with Disease Progression. Journal of Infectious 
Diseases 170: 293-298. 
56. Pang X, Humar A, Preiksaitis JK (2008) Concurrent Genotyping and Quantitation of Cytomegalovirus 
gB Genotypes in Solid-Organ-Transplant Recipients by Use of a Real-Time PCR Assay. J Clin 
Microbiol 46: 4004-4010. 
57. Čičin-Šain L, Podlech J, Messerle M, Reddehase MJ, Koszinowski UH (2005) Frequent Coinfection of 
Cells Explains Functional In Vivo Complementation between Cytomegalovirus Variants in the 
Multiply Infected Host. Journal of Virology 79: 9492-9502. 
58. Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, et al. (2013) Polymorphism in human 
cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural 
killer cells. J Biol Chem 288: 8679-8690. 
59. Smith C, Gras S, Brennan RM, Bird NL, Valkenburg SA, et al. (2014) Molecular Imprint of Exposure to 
Naturally Occurring Genetic Variants of Human Cytomegalovirus on the T cell Repertoire. Sci Rep 
4. 
60. Gibson L, Dooley S, Trzmielina S, Somasundaran M, Fisher D, et al. (2007) Cytomegalovirus (CMV) 
IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in 
infants. J Infect Dis 195: 1789-1798. 
61. Pfeiffer JK, Kirkegaard K (2005) Increased fidelity reduces poliovirus fitness and virulence under 
selective pressure in mice. PLoS Pathog 1: e11. 
62. Pfeiffer JK, Kirkegaard K (2003) A single mutation in poliovirus RNA-dependent RNA polymerase 
confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl Acad Sci U S 
A 100: 7289-7294. 
 
 
  
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/009571doi: bioRxiv preprint first posted online Sep. 25, 2014; 
Figure 1: HCMV Intrahost genetic diversity as compared to RNA viruses. Viral intrahost diversities 
are represented as circles with the diameters, drawn on a log scale, representing reported values of 
diversity. The genetic diversity of HCMV populations is comparable to those of RNA viruses, an 
unexpected result given that HCMV is a large dsDNA virus. Values were obtained from [16] and 
references therein. Abbreviations are as follows: WNV: West Nile Virus, HCMV: human cytomegalovirus, 
DENV: dengue virus, HCV: hepatitis C virus. Scale bar represents the diameter of a genetic diversity 
value of 0.1%. 
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Figure 2: Models of HCMV Diversity and Evolution. Panel A shows an example of the structure of an 
HCMV intrahost population. Minor variants in the population are distributed around a central sequence. 
Most variants are only a few mutational steps away from this central sequence. This distribution of 
sequences is known as a star phylogeny and can be formed by the high levels of replication associated 
with primary infection, where most de novo mutations will be rare and shared by few members of the 
population. Panel B shows a more complicated population structure which could result from reinfection. 
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In this example, the blue and red dashed lines represent strains, with minor variants radiating from the 
central sequence of each strain. The genetic distance between strains is significantly greater than the 
genetic distance of minor variants from their respective central sequences. Panel C depicts a model of 
HCMV evolution derived from congenital infection data. In this model, the peripheral blood harbors the 
most diverse sub-population of HCMV within the body. During dissemination to distal compartments, the 
viral population can rapidly evolve, either due to natural selection or stochastic mechanisms such as 
population bottlenecks, leading to populations in the distal tissues or organs being genetically 
differentiated from the peripheral blood compartment. This phenomenon is known as 
compartmentalization. The populations in the distal compartments are also less genetically diverse than 
those of the peripheral blood. Once HCMV has disseminated to compartments or if the virus remains in 
the peripheral blood, the populations become relatively stable and many mutations remain at similar 
frequencies over time. 
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